$ cat ./records/gates-foundation-and-dfid-commit-51-5-million-to-galvmed-for-live-2012.txt
Gates Foundation and DFID Commit $51.5 Million to GALVmed for Livestock Vaccine Development Including Tick-Borne Disease
[RECORD.TXT] · cat --full
The Bill & Melinda Gates Foundation (80%) and the UK Department for International Development (20%) jointly committed $51.5 million to GALVmed — the Global Alliance for Livestock Veterinary Medicines — for a five-year Phase 2 program running 2012–2017. A major focus was the East Coast fever vaccine and support for the African Union's Centre for Ticks and Tick-Borne Diseases in Lilongwe, Malawi, which produces the live Muguga cocktail vaccine against the tick-transmitted disease that kills one million cattle per year across East and Central Africa. GALVmed also worked to register and distribute vaccines for babesiosis and anaplasmosis — both tick-borne cattle diseases.
Free forever · No ads · Solo developer
If this was worth a read, help make the next entry possible.
Every entry in this archive was researched, verified, and written by one person — for free. No corporate funding. No ad revenue. Just a developer who believes verified history should be accessible to everyone. Your donation directly funds new entries.
Crypto accepted · No subscription required
← Previous
Gates Foundation Funds ECF Infection-and-Treatment Method Roll-Out for East African Smallholder Farmers
Next →
Boris Nikolic's Emails Coordinating Gates-Epstein Meetings Come Under Scrutiny
[CROSS_REFERENCES] · grep --category='Global Health'
Related Accomplishments
January 2026
Gates-backed World Mosquito Program reaches 16 million people protected from dengue via Wolbachia method
The World Mosquito Program — backed in part by the Gates Foundation — announced in January 2026 that its Wolbachia-infected mosquito releases had reached over 16.1 million people across multiple countries, including Colombia, Indonesia, Brazil, Sri Lanka, Fiji, Vanuatu, and Vietnam. Wolbachia-carrying Aedes aegypti mosquitoes — which block dengue, Zika, chikungunya, and yellow fever transmission — had established self-sustaining populations in treated cities without requiring ongoing releases. Gold-standard randomised trials in Indonesia showed a 77% reduction in dengue incidence. The program represented one of the largest and most cost-effective vector control deployments in history.
2025
Gates-Funded Monoclonal Antibody Shows Early Promise as a Single-Shot Malaria Shield
[ARCHIVE_FUNDING] · INDEPENDENT · NO ADS
One developer. >300 verified entries. Zero ads. Forever free.
No sponsors, no paywall, no algorithm. If this archive has been useful to you, reader support is what keeps it running.